It has been observed that only PD-L2 expression is an independent predictor of response to immunotherapy in HNSCC, whereas the positivity to both PD-L1 and PD-L2 confers a greater response than PD-L1 positivity alone. Here, PDCD1LG2 is linked to head and neck squamous cell carcinoma.